Research Article

Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM

Table 1

Baseline characteristics of patients from Turkey with newly diagnosed diabetic macular edema.

Age, mean (SD; min–max)61.3 (9.9; 20–88)
Sex, n (%)
Male522 (55.2)
Female423 (44.8)
Body mass index (kg/m2), mean (SD)28.9 (5.4)
Systolic blood pressure (mmHg), mean (SD)132.3 (15.6)
Diastolic blood pressure (mmHg), mean (SD)83.5 (11.6)
Hypertension
Present521 (55.1)
Undertreatmenta404 (77.5)
On dialysis13 (5.7)
Diabetes
Type 134 (3.6)
Type 2911 (96.4)
Undertreatmentb619 (65.5)
Diabetic foot disease44 (4.7)
Time from onset of diabetes to DME diagnosis, n (%)
Less than 5 years113 (12.0)
5–9 years200 (21.2)
10–14 years279 (29.5)
15–19 years193 (20.4)
20 years +160 (16.9)
Disciplines involved in diabetes follow-up care, n (%)
None (not followed up)165 (17.5)
Endocrinology267 (28.3)
Internal medicine444 (47.0)
Family practice65 (6.9)
Nephrology4 (0.4)
Blood biochemistry ()
Fasting blood glucose (mg/dL)
N206
 Mean (SD)187.8 (81.9)
HbA1c (%)
N165
 Mean (SD)8.8 (2.3)
Total cholesterol (mg/dL)
N99
 Mean (SD)203.7 (61.2)
LDL (mg/dL)
N114
 Mean (SD)124.5 (42.0)
HDL (mg/dL)
N98
 Mean (SD)47.7 (21.3)
Triglyceride (mg/dL)
N113
 Median (min–max)142 (43–880)
Urea (mg/dL)
N127
 Median (min–max)28.8 (4.4–178)
Creatinine (mg/dL)
N140
 Median (min–max)0.9 (0.4–7.0)
Microalbuminuria (mg/dL)
N36
 Median (min–max)25 (0–741)

Missing data for a27 and b130 patients.